T&R Biofab Co., Ltd. (KOSDAQ:246710)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,895.00
+20.00 (0.70%)
Apr 3, 2026, 3:30 PM KST
Market Cap137.71B +110.2%
Revenue (ttm)26.97B +453.3%
Net Income-34.94B
EPS-1,093.00
Shares Out47.57M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume327,458
Average Volume429,385
Open2,990.00
Previous Close2,875.00
Day's Range2,820.00 - 3,040.00
52-Week Range1,127.00 - 4,925.00
Beta0.61
RSI46.12
Earnings DateJun 1, 2026

About T&R Biofab

T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 246710
Full Company Profile

Financial Performance

In 2025, T&R Biofab's revenue was 26.97 billion, an increase of 453.32% compared to the previous year's 4.87 billion. Losses were -34.94 billion, 355.1% more than in 2024.

Financial Statements